Skip to main content

Table 2 Clinical and laboratory characteristics of the study population

From: The significance of fibroblast growth factor-2 and kidney injury molecule-1 as biomarker of interstitial renal fibrosis in glomerulonephritis

 

Mean

Standard deviation

Median

Minimum

Maximum

Age (years)

29.71

7.79

27.50

19.00

52.00

Creat (mg)

1.50

0.55

1.50

0.60

2.50

Urea (mg)

58.45

39.63

41.00

7.00

170.00

FBS (mg)

93.87

7.42

91.50

78.00

120.00

Na (mg)

134.95

4.33

135.00

114.00

141.00

K (mg)

4.45

0.73

4.40

2.10

5.80

Albumin

2.48

0.58

2.60

1.20

3.80

Proteinuria (g/24 h)

3.95

1.40

3.95

1.00

8.00

Ca (mg)

8.01

0.78

8.00

6.00

10.40

Phos (mg)

4.49

0.84

4.30

2.90

7.00

Hb (gm)

10.18

1.40

10.15

7.50

14.20

TLC (cell)

7.00

3.07

6.20

2.60

14.20

PLT

241.79

91.92

230.00

41.00

490.00

RBCs in urine

8.90

13.93

5.00

0.00

70.00

WBCs in urine

3.25

2.42

3.00

0.00

12.00

GFR (min/ml/h)

65.49

29.59

50.00

30.00

130.00

Fibrosis (%)

18.00

16.45

15.00

0.00

60.00

KIM-1 (pg/ml)

39.95

36.27

34.40

2.10

125.00

FGF-2 (ng/ml)

47.90

41.74

42.00

1.00

140.00